The Genomic Atlas of Breast Cancer — the non-coding theme
| Chr | chr7 |
| start | 129770383 |
| end | 129770492 |
| ID | MI0000272 |
| miRNA_name | hsa-miR-182 |
| methods | qRT-PCR,etc. |
| regulated | up |
| Function Description | Results: miRNA 182 expression was significantly higher in group II, group IV, and group V (3.36 ¡À 0.14, 2.52 ¡À 0.34, and 4.93 ¡À 0.3,9 respectively); miRNA 375 expression was significantly higher in group II, group IV, and group V (4.41 ¡À 0.40, 3.12 ¡À 0.35, and 11.28 ¡À 2.37, respectively) (P < .05). Both miRNAs were significantly associated with each other and with receptors used for the prognosis of BC even after multiple regression analysis.Conclusion: Accordingly, miRNAs 182 and 375 could be potential noninvasive markers used for the follow up of BC patients. |
| PMID | 30143449 |
| year | 2018 |
| Title | MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer |
| drug | X |
| circulating | V |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China
